BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10899792)

  • 1. Pathophysiology, prevention, and potential treatment of neural tube defects.
    Manning SM; Jennings R; Madsen JR
    Ment Retard Dev Disabil Res Rev; 2000; 6(1):6-14. PubMed ID: 10899792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology, pathogenesis and prevention of neural tube defects.
    Padmanabhan R
    Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants.
    Harris MJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):331-9. PubMed ID: 19117321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of neural tube defects: investigating preventive mechanisms.
    Greene ND; Copp AJ
    Am J Med Genet C Semin Med Genet; 2005 May; 135C(1):31-41. PubMed ID: 15800852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of spinal neural tube defects in the curly tail mouse mutant by a specific effect of retinoic acid.
    Chen WH; Morriss-Kay GM; Copp AJ
    Dev Dyn; 1994 Feb; 199(2):93-102. PubMed ID: 8204910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure.
    Harris MJ; Juriloff DM
    Birth Defects Res A Clin Mol Teratol; 2010 Aug; 88(8):653-69. PubMed ID: 20740593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
    Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
    Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An essay on research into the causation and prevention of spina bifida.
    Seller MJ
    Z Kinderchir; 1981 Dec; 34(4):306-14. PubMed ID: 7036574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid, methylation and neural tube closure in humans.
    Blom HJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):295-302. PubMed ID: 19301298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos.
    Greene ND; Dunlevy LE; Copp AJ
    Anat Embryol (Berl); 2003 Feb; 206(3):185-91. PubMed ID: 12592569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population.
    Richter B; Stegmann K; Röper B; Böddeker I; Ngo ET; Koch MC
    J Hum Genet; 2001; 46(3):105-9. PubMed ID: 11310576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications.
    Zetterberg H
    Reprod Biol Endocrinol; 2004 Feb; 2():7. PubMed ID: 14969589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of a neural tube defect recurrence-prevention program.
    Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
    Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing neural tube defects in Europe: a missed opportunity.
    Busby A; Abramsky L; Dolk H; Armstrong B; Addor MC; Anneren G; Armstrong N; Baguette A; Barisic I; Berghold A; Bianca S; Braz P; Calzolari E; Christiansen M; Cocchi G; Daltveit AK; De Walle H; Edwards G; Gatt M; Gener B; Gillerot Y; Gjergja R; Goujard J; Haeusler M; Latos-Bielenska A; McDonnell R; Neville A; Olars B; Portillo I; Ritvanen A; Robert-Gnansia E; Rösch C; Scarano G; Steinbicker V
    Reprod Toxicol; 2005; 20(3):393-402. PubMed ID: 15927445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.
    Cogram P; Hynes A; Dunlevy LP; Greene ND; Copp AJ
    Hum Mol Genet; 2004 Jan; 13(1):7-14. PubMed ID: 14613966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of neural tube defects in births before and after promotion of periconceptional folic acid supplementation].
    van der Pal-de Bruin KM; Buitendijk SE; Hirasing RA; den Ouden AL
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1732-6. PubMed ID: 10992899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China.
    Chen G; Song X; Ji Y; Zhang L; Pei L; Chen J; Liu J; Li C; Zheng X
    Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):592-6. PubMed ID: 18634013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
    Zlotogora J; Amitai Y; Leventhal A
    Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
    Gos M; Szpecht-Potocka A
    J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid intake and its effects on the prevention of neural tube defects, the masking of vitamin B12 deficiency and the reduction of homocysteine.
    Leyva M
    J Okla State Med Assoc; 2002 May; 95(5):339-42. PubMed ID: 12043109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.